Successful PBSC Mobilization with High-Dose G-CSF for Patients Failing a First Round of Mobilization
Authors:
- Cesar O. FreytesCFCesar O. Freytes
- Natalie CallanderNCNatalie Callander
- Tsuong-Wu TsaiTTTsuong-Wu Tsai
- Melissa AlsinaMAMelissa Alsina
- Jeanne AndersonJAJeanne Anderson
- Lisa HolleLHLisa Holle
- Jose C RuzJRJose C Ruz
- Pat DevorePDPat Devore
- Mike McGrathMMMike McGrath
- Gary WestGWGary West
- Robert AlvarezRARobert Alvarez
- 1 April 1999
- journal article
- research article
- Published by SAGE Publications in Journal of Hematotherapy
- Vol. 8 (2) , 173-183
Abstract
PBSC are the preferred source of stem cells for autologous transplantation. However, regardless of the mobilization procedure used, 10%-20% of patients fail to collect an adequate number to ensure prompt engraftment. There is as yet no standard mobilization procedure for patients who fail a first mobilization attempt. Here, we describe a highly efficient strategy to obtain an adequate number of stem cells for patients who failed a first mobilization attempt. Seventy-four patients with various hematologic malignancies underwent initial mobilization with various regimens including hematopoietic growth factors with or without chemotherapy. In 72% of patients, 2 X 10 6 CD34+ stem cells/kg were collected in the initial mobilization attempt, and patients engrafted in a median of 10 days for neutrophils and 12 days for platelets. Eighteen patients failed to mobilize adequate numbers of stem cells, defined as the inability to collect 0.2 X 10 6 CD34+ stem cells/kg/day in the first 2-3 days. These patients had their apheresis halted. Patients were immediately given G-CSF (32 mu g/kg/day) for 4 days as a second attempt at mobilization. Eighty-eight percent of these patients achieved the target of 2 X 10 6 CD34+ cells/kg, with a median duration of apheresis of 5 days (including the first and second mobilizations). The mean CD34+ cells/kg/day increased after administration of high-dose G-CSF from 0.16 after the first mobilization attempt to 0.61 (p = 0.0002) after the second mobilization. All patients engrafted in a median of 11 and 13 days for neutrophils and platelets, respectively. We conclude that patients whose apheresis yield is <0.4 X 10 6 CD34+ cells/kg after the first two apheresis collections can be successfully mobilized if high-dose G-CSF is administered immediately and continued until achieving 2 X 10 6 CD34+ stem cells/kg.Keywords
This publication has 20 references indexed in Scilit:
- Second Attempts at Mobilization of Peripheral Blood Stem Cells in Patients with Initial Low CD34+ Cell YieldsJournal of Hematotherapy, 1998
- Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastimBritish Journal of Haematology, 1998
- The ISHAGE Guidelines for CD34+ Cell Determination by Flow CytometryJournal of Hematotherapy, 1996
- Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factorBlood, 1996
- Cytokine enhancement of peripheral blood stem cellsStem Cells, 1996
- Optimization of Peripheral Blood Stem Cell MobilizationStem Cells, 1996
- Autologous Transplantation with Tumor-Free Graft: A Model for Multiple Myeloma PatientsLeukemia & Lymphoma, 1996
- An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapyBlood, 1995
- Use of granulocyte colony‐stimulating factor (G‐CSF) for mobilizing peripheral blood stem cells: risk of mobilizing clonal myeloma cells in patients with bone marrow infiltrationBritish Journal of Haematology, 1994
- GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATIONThe Lancet, 1989